-
Electronic (PDF)
-
Site License
-
Enterprisewide
Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2013, Pages: 53
Summary
Affymetrix, Inc. (Affymetrix) is a medical equipment company. It carries out the development, production, sales and service of consumables and equipment systems for genetic analysis in the life sciences and clinical healthcare markets. It offers products for two applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument systems, namely, GeneChip, GeneTitan and GeneAtlas that include instruments, consumables and software. The company’s platform is based on its GeneChip system and related microarray technology, which is used to acquire, analyze and manage complex genetic information. Affymetrix's products are widely used by pharmaceutical, biotechnology, agrichemical, diagnostic and consumer product companies, as well as academic, government and other non-profit research institutes. Its operations are spread across the US, Europe, Japan and several other regions. Affymetrix is headquartered in California, the US.
The company focuses on thoughtfully designed innovations, based on extensive consumer insight, to meet the needs of hospitals and clinics. Affymetrix envisages establishing its position through the development of innovative drugs and enhancement of existing ones, internal development, strong partner relationships, strategic collaborations and acquisitions.
Affymetrix, Inc. Key Recent Developments
Mar 22, 2013 Affymetrix Signs Contract With UK Biobank To Genotype 500,000 UK Individuals As Part Of Epidemiological Study
Jan 31, 2013 Affymetrix Reports Revenue Of $295.6m In 2012
Jan 08, 2013 Affymetrix Implements Corporate Restructuring, Reduces Workforce By 8%
Nov 06, 2012 Affymetrix Introduces Axiom miRNA Target Site Genotyping Arrays
This comprehensive SWOT profile of Affymetrix, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
Affymetrix, Inc. - Key Facts
Affymetrix, Inc. - Key Employees
Affymetrix, Inc. - Key Employee Biographies
Affymetrix, Inc. - Major Products and Services
Affymetrix, Inc. - Medical Equipment Pipeline Products Data
Affymetrix, Inc. Pipeline Products by Equipment Type
Affymetrix, Inc. Pipeline Products by Development Stage
Affymetrix, Inc. - History
Affymetrix, Inc. - Company Statement
Affymetrix, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affymetrix, Inc. - Key Manufacturing Facilities
Section 2 – Company Analysis
Affymetrix, Inc. - Business Description
Affymetrix, Inc. - Corporate Strategy
Affymetrix, Inc. - SWOT Analysis
SWOT Analysis - Overview
Affymetrix, Inc. - Strengths
Strength - Proprietary Technology
Strength - Strong Research and Development Activities
Strength - Successful Integration of eBioscience
Affymetrix, Inc. - Weaknesses
Weakness - Revenue Concentration: the US
Weakness - Reliance on Suppliers
Weakness - Limited Liquidity
Affymetrix, Inc. - Opportunities
Opportunity - Strategic Collaborations
Opportunity - Potential Market
Opportunity - Market Growth in Emerging Economies
Affymetrix, Inc. - Threats
Threat - Government Regulations
Threat - Intense Competition
Threat - Technological Changes
Affymetrix, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Affymetrix, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Affymetrix, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Affymetrix, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Affymetrix, Inc., Recent Developments
Jan 31, 2013: Affymetrix Reports Revenue Of $295.6m In 2012
Jan 08, 2013: Affymetrix Implements Corporate Restructuring, Reduces Workforce By 8%
Nov 06, 2012: Affymetrix Introduces Axiom miRNA Target Site Genotyping Arrays
Nov 06, 2012: Affymetrix Introduces Axiom miRNA Target Site Genotyping Arrays
Nov 05, 2012: Affymetrix Reports Revenue Of $79.6m In Q3 2012
Nov 01, 2012: Affymetrix Introduces Axiom Biobank Arrays For Genotyping Studies
Aug 02, 2012: Affymetrix Launches Advanced RNA Amplification Technology For Whole-Genome Expression Analysis Of FFPE Samples
Aug 01, 2012: Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology
Jul 31, 2012: Affymetrix Reports Revenue Of $66.4m In Q2 2012
Jun 18, 2012: Affymetrix Announces Public Offering Of Convertible Senior Notes Due 2019 For $105 Million
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
Affymetrix, Inc., Key Facts
Affymetrix, Inc., Key Employees
Affymetrix, Inc., Key Employee Biographies
Affymetrix, Inc., Major Products and Services
Affymetrix, Inc. Number of Pipeline Products by Equipment Type
Affymetrix, Inc. Pipeline Products by Equipment Type
Affymetrix, Inc. Number of Pipeline Products by Development Stage
Affymetrix, Inc. Pipeline Products by Development Stage
Affymetrix, Inc., History
Affymetrix, Inc., Other Locations
Affymetrix, Inc., Subsidiaries
Affymetrix, Inc., Key Manufacturing Facilities
Affymetrix, Inc., Key Competitors
Affymetrix, Inc., Ratios based on current share price
Affymetrix, Inc., Annual Ratios
Affymetrix, Inc., Interim Ratios
Affymetrix, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Affymetrix, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Affymetrix, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Affymetrix, Inc. Pipeline Products by Equipment Type
Affymetrix, Inc. Pipeline Products by Development Stage
Affymetrix, Inc., Performance Chart (2008 - 2012)
Affymetrix, Inc., Ratio Charts
Affymetrix, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Affymetrix, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013
Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
CombiMatrix Corporation
bioMerieux S.A.
F. Hoffmann-La Roche Ltd.
Life Technologies Corporation
Agilent Technologies, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
